BMC, July 2018
“Assessing cognition in patients with early Alzheimer’s disease – an experts views on the new FDA guidance”
EP Vantage, April 2018
“Probiodrug hopes to avoid Alzheimer’s amyloid abyss”
PharmaTimes magazine, April 2018
“Taking Alzheimer’s head-on”
Nature/Biopharma Dealmakers, November 2017
“Developing a new generation of Alzheimer’s disease treatments”
Manufacturing Chemist, October 2016
“Alzheimer´s disease: a new therapeutic strategy”
Nature/Biopharma Dealmakers, September 2015
“New therapeutic strategy for treating Alzheimer´s disease”